Interstitial lung diseases
Pulmonary vascular diseases
Respiratory critical care
State of the art session
Pulmonary vascular diseases
Clinical
Pulmonary hypertension in pulmonary disease
Aims : to summarise the vast progress that has been made in understanding and treatment of pulmonary hypertension related to underlying lung disease in recent years; to discuss the biology and epigenetic causes of pulmonary hypertension, and how this information may help to develop novel treatments; to provide an update about recent trials in pulmonary hypertension; to provide novel insights into the pulmonary vascular nature of low DLCO-related pulmonary hypertension.
Target audience :
Adult pulmonologist/Clinician, Clinical researcher, Medical Student, Respiratory critical care physician, Patient, Scientist (basic, translational)
Methods :
Imaging, Physiology, Respiratory intensive care
14:15
The origin and consequence of pulmonary hypertension in patients with lung-related disease
J. Barberà Mir(Barcelona, Spain)
COI
-
Description
1
2876
14:30
Pulmonary hypertension in patients with autoimmune disease
M. Humbert(Le Kremlin-Bicêtre, France)
COI
-
Description
2
2877
14:45
Failures and successes in treatment of pulmonary hypertension in patients with interstitial lung disease: past, present and future
A. Waxman(Boston, United States)
COI
-
Description
3
2878
15:00
Low DLCO in patients with pulmonary arterial hypertension: a different vascular phenotype?
E. Nossent(Amsterdam, Netherlands)
COI
-
Description
4
2879
15:15
Discussion and Q&A
5
2880
. . .
